DNAprint Genomics (DNAG)

[frogdreaming]

OT: oooh ...A mystery!
I love mysteries.
Let see, so far we have Biophan, or A Beckman Coulter competitor...Nah, too obvious.

It's probably someone who's really being beaten up in the marketplace as DNAP increases it's market share. I wonder who that could be?

We could start with all the markets in which DNAP is a major force.....No, let's not go there.

Hmmm...maybe it's someone like Perelgen who is using exactly the same approach to determine the underlying connections between the genome and drug response...Nah.. they already have 1.7 million snps identified and listed, it's doubtful that they are threatened by DNAP's 2500.

Maybe it's one of the drug giants...Lilly or Merke...Nah, if they had even a shiver of concern they could buy DNAP outright on the market for less than one days cafeteria budget.

Oh well... I give up. Who could it be?